Rodman & Renshaw Announces Panel Discussion
on Healthcare Reform
Panel Discussion to be Held Thursday, February 3rd at the Rodman & Renshaw NYC Headquarters
January 24, 2011 08:33 AM Eastern Time
NEW YORK--(EON: Enhanced Online News)--Rodman & Renshaw, LLC, a wholly owned subsidiary of
Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), a leading full service investment bank for
growth oriented companies today announced that on Thursday, February 3rd, 2011, Rodman will host a Healthcare
Reform Panel Discussion in its media center with the following panelists:
l General Wesley K. Clark, Chairman of Rodman & Renshaw, LLC, retired four star general after 38 years in
the United States Army
l James M. Mead, Vice Chairman of the Board of Capital BlueCross,Venture Partner with Radius Ventures,
LLC, served as President and CEO of Capital BlueCross for 20 years
l Dr. Peter Costantino, Executive Director of the New York Head and Neck Institute (NYHNI), Senior Vice
President of the Head and Neck Surgery Service Line North Shore-LIJ Health System
l Mark J. Solazzo, Executive Vice President and Chief Operating Officer of the North Shore-LIJ Health
The event will be moderated by Suraj Kalia, Senior Medical Device Analyst at Rodman & Renshaw, LLC. The
topics to be covered include: the current state of affairs in the healthcare landscape, the need for a structural shake-
up, effects of reform on company pricing strategies, hospital purchasing patterns, delivery of care, current political
posturing, and the impact of reform on consumers. The media has circulated a lot of misinformation about the risks
and benefits of the Patient Protection and Affordable Care Act in the media. Our panelists will attempt to separate
fact from fiction through three different perspectives: the policy perspective (General Wesley K. Clark), the managed
care perspective (James M. Mead), and the administrative/operations perspective (Dr. Peter Costantino, Mark J.
Background of Panelists:
General Wesley K. Clark - serves as Chairman and CEO of Wesley K. Clark & Associates, a strategic
consulting firm; Chairman of investment bank Rodman & Renshaw; Chairman of Emergya Wind Technologies
Americas; Co-Chairman of Growth Energy; senior fellow at UCLA's Burkle Center for International Relations;
Director of International Crisis Group; and Chairman of City Year Little Rock. General Clark has authored three
books and serves as a member of the Clinton Global Initiative's Energy & Climate Change Advisory Board, and
ACORE's Advisory Board. Clark retired a four star general after 38 years in the United States Army. He graduated
first in his class at West Point and completed degrees in Philosophy, Politics and Economics at Oxford University
(B.A. and M.A.) as a Rhodes Scholar. His awards include the Presidential Medal of Freedom, Defense
Distinguished Service Medal (five awards), Silver star, bronze star, purple heart, honorary knighthoods from the
British and Dutch governments, and numerous other awards from other governments, including award of
Commander of the Legion of Honor (France).
James M. Mead - is the Vice Chairman of the Board and Special Advisor to the Chief Executive Officer for
Capital BlueCross. He served as President and CEO of Capital BlueCross for 20 years. From 1988 to 2004, Mr.
Mead served on the Board of Directors of national BlueCross BlueShield Association. Prior to joining Capital
BlueCross, he was a member of the faculty of Penn State University and served as a health economist and special
assistant to the Pennsylvania Commissioner. He is a past Chairman of the Board of the Federal Reserve Bank of
Philadelphia. Mr. Mead is currently a Venture Partner with Radius Ventures, LLC (New York, NY), Chairman of
the Board of Trustees of the Pennsylvania Lawyers Fund for Client Security of the Supreme Court of Pennsylvania
(Harrisburg, PA). He also serves on several corporate Boards including the Boards of the Hershey Trust Company,
the Milton Hershey School and the Hershey Foundation.
Dr. Peter Costantino - is the Executive Director of the New York Head and Neck Institute, the Senior Vice
President for the Head and Neck Surgery Service Line North Shore-LIJ System, and the Director of the Center for
Cranial Base Surgery at Lenox Hill Hospital. Until recently, Dr. Costantino was a Professor of Otolaryngology and
the Director of the Cranial Base Surgery Program at Columbia University College of Physicians & Surgeons, and
remains an adjunct Professor in the Department of Otolaryngology-Head & Neck Surgery at the University of North
Carolina at Chapel Hill. He has substantial expertise in the development of implantable surgical devices and
biomaterial, having founded or significantly participated in the development of Parallax Medical (Arthorcare, inc.),
LifeCell Corporation (KCI International), BoneSource TM (Stryker Corporation), Revive TM (Biomerix
Corporation), and the Galen VII monitoring device (Galen Medical, LLC.). He has served as a consultant to a
number of medical companies, has published over 100 articles, chapters, and abstracts, holds a number of patents,
and lectures frequently. He currently sits on the Board of Directors for Biomerix Corporation.
Mark J. Solazzo -is the Executive Vice President and Chief Operating Officer of the North Shore-LIJ Health
System. Prior to 2005, Mr. Solazzo served as Chief of Staff and Chief Administrative officer to the North Shore-LIJ
Health System’s President and Chief Executive Officer. Mr. Solazzo held a number of positions in his fifteen year
tenure at the New York State Department of Social Services. He earned Harvard University’s Innovations in
Government Award for his work on New York’s Child Assistance Program. Mr. Solazzo is a member of the
Healthcare Institute, Inc., the Health Management Academy, and the Healthcare Association of New York State.
He is an adjunct Professor of Health Care Management at St. Joseph’s College in Patchogue, NY.
The presentation will take place at the Rodman & Renshaw Offices (1251 Avenue of the Americas, 20th Floor,
New York, NY 10020)at 4:30PM on February 3rd, 2011.
To attend, please RSVP to Jake Rynar at email@example.com. Please respond quickly as space is limited. This event
also will be webcast live at http://rodm.tv/broadcast.php, and a dial-in number is available upon request. A replay of
the discussion will be made available at www.rodm.tv 24-hours after completion of the event.
About Rodman & Renshaw
Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and
indirect subsidiaries, including Rodman & Renshaw, LLC.
Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory
and related services to public and private companies across multiple sectors and regions. Rodman also provides
research and sales and trading services to institutional investors. Rodman is the leader in the PIPE (private investment
in public equity) and RD (registered direct offering) transaction markets. According to Sagient Research Systems,
Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing
transactions completed every year since 2005.
For more information visit Rodman & Renshaw on the Internet at www.rodm.com
Rodman & Renshaw, LLC ("Rodman") reserves the right in its sole discretion to accept or reject registration
for, or admission to, all or any portion of our panel discussions. Rodman sponsors the Healthcare Reform
Panel discussion. Rodman does not prepare, review or edit the presentations and other information provided
by the participating panelists, and does not take any responsibility for the accuracy or adequacy of any such
information as the basis for any investment decision. Rodman is not providing any person with any
investment advice through their participation in or attendance to this panel discussion, nor is Rodman
soliciting any offers to buy or sell any securities. Member FINRA, SIPC.
MEMBER FINRA SIPC
For more on information on Rodman & Renshaw:
Rodman & Renshaw, LLC
Jake Rynar, 212-356-0530